Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating infliximab in Chinese patients with active ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED